Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2012, Article ID 647594, 10 pages
http://dx.doi.org/10.1155/2012/647594
Review Article

Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation

1Department of Molecular Patho-Physiology, Faculty of Pharmaceutical Science, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-8510, Japan
2Center for Drug Delivery Research, Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-8510, Japan

Received 30 July 2011; Accepted 7 September 2011

Academic Editor: Jun Chung

Copyright © 2012 Takuya Iyoda and Fumio Fukai. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Bornstein and E. H. Sage, “Matricellular proteins: extracellular modulators of cell function,” Current Opinion in Cell Biology, vol. 14, no. 5, pp. 608–616, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Murphy-Ullrich, “The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?” Journal of Clinical Investigation, vol. 107, no. 7, pp. 785–790, 2001. View at Google Scholar · View at Scopus
  3. F. Fukai, S. Hasebe, M. Ueki et al., “Identification of the anti-adhesive site buried within the heparin-binding domain of fibronectin,” Journal of Biochem, vol. 121, no. 2, pp. 189–192, 1997. View at Google Scholar
  4. S. Kamiya, R. Kato, M. Wakabayashi et al., “Fibronectin peptides derived from two distinct regions stimulate adipocyte differentiation by preventing fibronectin matrix assembly,” Biochemistry, vol. 41, no. 9, pp. 3270–3277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Watanabe, H. Takahashi, Y. Habu et al., “Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin,” Biochemistry, vol. 39, no. 24, pp. 7138–7144, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Chigaev, A. M. Blenc, J. V. Braaten et al., “Real time analysis of the affinity regulation of α 4-integrin: the physiologically activated receptor is intermediate in affinity between resting and Mn2+ or antibody activation,” Journal of Biological Chemistry, vol. 276, no. 52, pp. 48670–48678, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. Y. Saito, H. Imazeki, S. Miura et al., “A peptide derived from tenascin-C induces β1 integrin activation through syndecan-4,” Journal of Biological Chemistry, vol. 282, no. 48, pp. 34929–34937, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. D. A. Williams, M. Rios, C. Stephens, and V. P. Patel, “Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions,” Nature, vol. 352, no. 6334, pp. 438–441, 1991. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. K. H. Shain, T. H. Landowski, and W. S. Dalton, “The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance,” Current Opinion in Oncology, vol. 12, no. 6, pp. 557–563, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Sachs, “The adventures of a biologist: prenatal diagnosis, hematopoiesis, leukemia, carcinogenesis, and tumor suppression,” Advances in Cancer Research, vol. 66, pp. 1–40, 1995. View at Google Scholar · View at Scopus
  11. K. F. Bradstock and D. J. Gottlieb, “Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease,” Leukemia and Lymphoma, vol. 18, no. 1-2, pp. 1–16, 1995. View at Google Scholar · View at Scopus
  12. R. W. Hurley, J. B. McCarthy, and C. M. Verfaillie, “Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation,” Journal of Clinical Investigation, vol. 96, no. 1, pp. 511–519, 1995. View at Google Scholar · View at Scopus
  13. A. Molla and M. R. Block, “Adherence of human erythroleukemia cells inhibits proliferation without inducing differentiation,” Cell Growth and Differentiation, vol. 11, no. 2, pp. 83–90, 2000. View at Google Scholar · View at Scopus
  14. J. S. Damiano, L. A. Hazlehurst, and W. S. Dalton, “Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation,” Leukemia, vol. 15, no. 8, pp. 1232–1239, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Chilosi, M. Lestani, A. Benedetti et al., “Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues,” American Journal of Pathology, vol. 143, no. 5, pp. 1348–1355, 1993. View at Google Scholar · View at Scopus
  16. G. Ocklind, J. Talts, R. Fassler, A. Mattsson, and P. Ekblom, “Expression of tenascin in developing and adult mouse lymphoid organs,” Journal of Histochemistry and Cytochemistry, vol. 41, no. 8, pp. 1163–1169, 1993. View at Google Scholar · View at Scopus
  17. T. Atula, J. Hedström, P. Finne, I. Leivo, M. Markkanen-Leppänen, and C. Haglund, “Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma,” Anticancer Research, vol. 23, no. 3, pp. 3051–3056, 2003. View at Google Scholar · View at Scopus
  18. A. Leins, P. Riva, R. Lindstedt, M. S. Davidoff, P. Mehraein, and S. Weis, “Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma,” Cancer, vol. 98, no. 11, pp. 2430–2439, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. Y. Saito, T. Owaki, T. Matsunaga et al., “Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4,” Journal of Biological Chemistry, vol. 285, no. 10, pp. 7006–7015, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. H. Sugahara, Y. Kanakura, T. Furitsu et al., “Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5,” Journal of Experimental Medicine, vol. 179, no. 6, pp. 1757–1766, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Terui, Y. Furukawa, T. Sakai et al., “Up-regulation of VLA-5 expression during monocytic differentiation and its role in negative control of the survival of peripheral blood monocytes,” Journal of Immunology, vol. 156, no. 5, pp. 1981–1988, 1996. View at Google Scholar · View at Scopus
  22. R. Kapur, R. Cooper, L. Zhang, and D. A. Williams, “Cross-talk between α4β1/α5β1 and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways,” Blood, vol. 97, no. 7, pp. 1975–1981, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Matsunaga, N. Takemoto, T. Sato et al., “Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia,” Nature Medicine, vol. 91, pp. 158–165, 2005. View at Google Scholar · View at Scopus
  24. L. A. Hazlehurst and W. S. Dalton, “Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies,” Cancer and Metastasis Reviews, vol. 20, no. 1-2, pp. 43–50, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Matsunaga, F. Fukai, S. Miura et al., “Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia,” Leukemia, vol. 22, no. 2, pp. 353–360, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. W. J. Wang, U. Consoli, C. M. Lane et al., “Rescue from apoptosis in early (CD34-selected) versus late (Non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells,” Cell Growth and Differentiation, vol. 9, no. 2, pp. 105–112, 1998. View at Google Scholar · View at Scopus
  27. J. S. Damiano, A. E. Cress, L. A. Hazlehurst, A. A. Shtil, and W. S. Dalton, “Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines,” Blood, vol. 93, no. 5, pp. 1658–1667, 1999. View at Google Scholar · View at Scopus
  28. J. P. Lévesque, D. I. Leavesley, S. Niutta, M. Vadas, and P. J. Simmons, “Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins,” Journal of Experimental Medicine, vol. 181, no. 5, pp. 1805–1815, 1995. View at Google Scholar · View at Scopus
  29. Y. Yamashita, K. Oritani, E. K. Miyoshi, R. Wall, M. Bernfield, and P. W. Kincade, “Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes,” Journal of Immunology, vol. 162, no. 10, pp. 5940–5948, 1999. View at Google Scholar
  30. N. C. Kaneider, P. Egger, S. Dunzendorfer, and C. J. Wiedermann, “Syndecan-4 as antithrombin receptor of human neutrophils,” Biochemical and Biophysical Research Communications, vol. 287, no. 1, pp. 42–46, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. L. Coulombel, M. H. Vunillet, C. Leroy, and G. Tchernia, “Linage- and stage-specific adhesion of human hematopoetic progenitor cells to extracellular matrices from marrow fibroblasts,” Blood, vol. 71, pp. 329–334, 1988. View at Google Scholar
  32. D. A. Williams, “Molecular analysis of the hematopoietic microenvironment,” Pediatric Research, vol. 36, no. 5, pp. 557–560, 1994. View at Google Scholar · View at Scopus
  33. K. G. Murti, P. S. Brown, M. A. Kumagai, and D. Campana, “Molecular interactions between human B-cell progenitors and the bone marrow microenvironment,” Experimental Cell Research, vol. 226, no. 1, pp. 47–58, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. B. R. Clark, J. T. Gallagher, and T. M. Dexter, “Cell adhesion in the stromal regulation of haemopoiesis,” Bailliere's Clinical Haematology, vol. 5, no. 3, pp. 619–652, 1992. View at Google Scholar · View at Scopus
  35. A. Wilson and A. Trumpp, “Bone-marrow haematopoietic-stem-cell niches,” Nature Reviews Immunology, vol. 6, no. 2, pp. 93–106, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. V. P. Patel and H. F. Lodish, “A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes,” Journal of Cell Biology, vol. 105, no. 6, pp. 3105–3118, 1987. View at Google Scholar · View at Scopus
  37. M. H. Vuillet-Gaugler, J. Breton-Gorius, W. Vainchenker et al., “Loss of attachment to fibronectin with terminal human erythroid differentiation,” Blood, vol. 75, no. 4, pp. 865–873, 1990. View at Google Scholar · View at Scopus
  38. T. Tada, D. T. Widayati, and K. Fukuta, “Morphological study of the transition of haematopoietic sites in the developing mouse during the peri-natal period,” Journal of Veterinary Medicine Series C, vol. 35, no. 4, pp. 235–240, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. R. Weinstein, M. A. Riordan, K. Wenc, S. Kreczko, M. Zhou, and N. Dainiak, “Dual role of fibronectin in hematopoietic differentiation,” Blood, vol. 73, no. 1, pp. 111–116, 1989. View at Google Scholar · View at Scopus
  40. S. Eshghi, M. G. Vogelezang, R. O. Hynes, L. G. Griffith, and H. F. Lodish, “α4β1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development,” Journal of Cell Biology, vol. 177, no. 5, pp. 871–880, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. T. Papayannopoulou, G. V. Priestley, and B. Nakamoto, “Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway,” Blood, vol. 91, no. 7, pp. 2231–2239, 1998. View at Google Scholar · View at Scopus
  42. J. C. M. Van Der Loo, X. Xiao, D. McMillin, K. Hashino, I. Kato, and D. A. Williams, “VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin,” Journal of Clinical Investigation, vol. 102, no. 5, pp. 1051–1061, 1998. View at Google Scholar · View at Scopus
  43. N. Yanai, C. Sekine, H. Yagita, and M. Obinata, “Roles for integrin very late activation antigen-4 in stroma-dependent erythropoiesis,” Blood, vol. 83, no. 10, pp. 2844–2850, 1994. View at Google Scholar · View at Scopus
  44. K. Hamamura, H. Matsuda, Y. Takeuchi, S. Habu, H. Yagita, and K. Okumura, “A critical role of VLA-4 in erythropoiesis in vivo,” Blood, vol. 87, no. 6, pp. 2513–2517, 1996. View at Google Scholar · View at Scopus
  45. R. Tanaka, T. Owaki, S. Kamiya et al., “VLA-5-mediated adhesion to fibronectin accelerates hemin-stimulated erythroid differentiation of K562 cells through induction of VLA-4 expression,” Journal of Biological Chemistry, vol. 284, no. 30, pp. 19817–19825, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. M. J. Elices, L. Osborn, Y. Takada et al., “VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site,” Cell, vol. 60, no. 4, pp. 577–584, 1990. View at Publisher · View at Google Scholar · View at Scopus
  47. O. Witt, K. Sand, and A. Pekrun, “Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways,” Blood, vol. 95, no. 7, pp. 2391–2396, 2000. View at Google Scholar · View at Scopus
  48. Y. Nagata, N. Takahashi, R. J. Davis, and K. Todokoro, “Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation,” Blood, vol. 92, no. 6, pp. 1859–1869, 1998. View at Google Scholar · View at Scopus
  49. J. I. Park, H. S. Choi, J. S. Jeong, J. Y. Han, and I. H. Kim, “Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells,” Cell Growth and Differentiation, vol. 12, no. 9, pp. 481–486, 2001. View at Google Scholar · View at Scopus
  50. W. Woessmann and N. F. Mivechi, “Role of ERK activation in growth and erythroid differentiation of K562 cells,” Experimental Cell Research, vol. 264, no. 2, pp. 193–200, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. R. Di Pietro, V. Di Giacomo, L. Caravatta, S. Sancilio, R. A. Rana, and A. Cataldi, “Cyclic nucleotide Response Element Binding (CREB) protein activation is involved in K562 erythroleukemia cells differentiation,” Journal of Cellular Biochemistry, vol. 100, no. 4, pp. 1070–1079, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. M. Seki, J. Kameoka, S. Takahashi et al., “Identification of tenascin-C as a key molecule determining stromal cell-dependent erythropoiesis,” Experimental Hematology, vol. 34, no. 4, pp. 519–527, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. A. Siri, V. Knauper, N. Veirana, F. Caocci, G. Murphy, and L. Zardi, “Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases,” Journal of Biological Chemistry, vol. 270, no. 15, pp. 8650–8654, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Ilić, E. A. C. Almeida, D. D. Schlaepfer, P. Dazin, S. Aizawa, and C. H. Damsky, “Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis,” Journal of Cell Biology, vol. 143, no. 2, pp. 547–560, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. S. M. Frisch and R. A. Screaton, “Anoikis mechanisms,” Current Opinion in Cell Biology, vol. 13, no. 5, pp. 555–562, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Claesson-Welsh, “Platelet-derived growth factor receptor signals,” Journal of Biological Chemistry, vol. 269, no. 51, pp. 32023–32026, 1994. View at Google Scholar · View at Scopus
  57. P. Chiarugi, “From anchorage dependent proliferation to survival: lessons from redox signalling,” IUBMB Life, vol. 60, no. 5, pp. 301–307, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. A. El-Karef, T. Yoshida, E. C. Gabazza et al., “Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice,” Journal of Pathology, vol. 211, no. 1, pp. 86–94, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. T. Nishioka, K. Onishi, N. Shimojo et al., “Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice,” American Journal of Physiology, vol. 298, no. 3, pp. H1072–H1078, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. K. Midwood, S. Sacre, A. M. Piccinini et al., “Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease,” Nature Medicine, vol. 15, no. 7, pp. 774–780, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. E. H. Sage, “Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis,” Trends in Cell Biology, vol. 7, no. 5, pp. 182–186, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. G. E. Davis, K. J. Bayless, M. J. Davis, and G. A. Meininger, “Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules,” American Journal of Pathology, vol. 156, no. 5, pp. 1489–1498, 2000. View at Google Scholar · View at Scopus
  63. T. Truong, G. Sun, M. Doorly, J. Y. J. Wang, and M. A. Schwartz, “Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 18, pp. 10281–10286, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. M. A. Schwartz, K. McRoberts, M. Coyner et al., “Integrin agonists as adjuvants in chemotherapy for melanoma,” Clinical Cancer Research, vol. 14, no. 19, pp. 6193–6197, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. D. G. Stupack, X. S. Puente, S. Boutsaboualoy, C. M. Storgard, and D. A. Cheresh, “Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins,” Journal of Cell Biology, vol. 155, no. 4, pp. 459–470, 2001. View at Google Scholar · View at Scopus